-
US envoy to meet Russia's president after 'productive' talks with Zelensky
-
Man in court over alleged 'targeted' attack on Australia lawmaker
-
LeBron optimistic after launching Sixers era with win
-
As actors get more physical, Bollywood embraces intimacy coordinators
-
Fear as Indians struggle to prove voting rights
-
Brazil's presidential candidates seek to disqualify each other
-
Asian stocks rally as tech firms enjoy bounce ahead of key earnings
-
French PM to meet unions as government prepares for more protests
-
LeBron, Sixers spoil Knicks party as NBA season tips off
-
'To the shelter, quickly!' Air raids reshape Kyiv school life
-
Man in court over alleged 'targeted' attack on Australian lawmaker
-
'Leave us alone!' DC golfers fear worst over Trump's course remodel
-
Regulator has 'power' to force Man City sale
-
NFL players union wants probe into Hurts' medical care
-
Man allegedly behind 'targeted' attack on Australian lawmaker appears in court
-
Man allegedly behind 'targeted' attack on Australian lawmaker due in court
-
Musk backs SpaceX-Tesla merger as rocket firm turns profit
-
Netflix shares drop on slowing engagement, revenue growth
-
Zelensky, US hail 'productive' talks to end Trump feud
-
Rodri needed a rest for Barcelona ahead of Clasico, says Flick
-
'Unbelievable' Foden back in the groove with treble in Man City rout
-
Musk says backs SpaceX-Tesla merger as rocket firm turns profit
-
Pistons rally to beat Celtics in NBA 2026-27 season opener
-
US regulators certify Boeing 737 MAX 10 after delays
-
PSG late show downs Barca in Champions League, Liverpool fight back
-
PSG strike late to get better of Yamal and Barcelona in Champions League
-
Liverpool strike back to beat Villarreal in seven-goal thriller
-
Foden hat-trick fuels Man City rout of AEK Athens
-
Dow boosted as markets rotate from tech shares
-
Trump says he wants Zelensky to 'make a deal' with Russia
-
Zelensky hails resumption of US advance warning of strikes on Ukraine
-
'I want it so badly': PSG heartbreak fuelling Arsenal, says Arteta
-
Carrick says only wins can ease doubts over Man Utd future
-
Lula campaign seeks to disqualify Bolsonaro over Meta 'interference'
-
Top NBA Draft pick Dybantsa to miss opener with ankle sprain
-
All who profited from fund scandal 'identified': Turkish minister
-
Italy sends troops, toughens security laws after Milan clashes
-
Christina Applegate says she was misdiagnosed with MS
-
Alberta separatists vow to fight on, risking turmoil for Canada
-
Ronaldo let Man Utd down says Ten Hag
-
Two men re-arrested for suspected spying for Iran in airbase scare: UK police
-
Meta says it complied with Brazil court order to treat candidates equally
-
Guatemalan man gets 30 years for truck smuggling deaths of 53 migrants
-
Inequality is major factor in impact of non-communicable diseases : WHO
-
'Clayface' gets under the skin of the superhero genre
-
Italy to send 500 troops to Milan after clashes
-
Zelensky, US envoys hold Oslo talks as Ukraine claims US missile holdup
-
BBC slashes 100 jobs, closes two channels
-
All-rounder Minhas stars as Pakistan crush England in tri-series
-
Tech jitters lead stocks lower, oil surges then slides
US House revolt advances Obamacare subsidy extension
US lawmakers voted Thursday to revive health insurance subsidies that expired at the end of last year, offering hope to millions of Americans facing steep premium hikes -- and pressuring the Senate to follow suit.
The bill, which passed with Democratic support and backing from a small bloc of Republicans defying their own leadership, would extend enhanced subsidies under the Affordable Care Act -- widely known as Obamacare -- for three years.
Those subsidies lower monthly insurance costs for Americans who buy coverage on government-run marketplaces.
Their expiration on January 1 more than doubled payments for many households, reigniting a politically sensitive debate over health care affordability in a year set to be dominated by the high-stakes midterm congressional elections.
Even supporters concede the House bill is unlikely to become law in its current form.
President Donald Trump has criticized the subsidies as wasteful and has urged Republicans to push for changes, though he has also told lawmakers they may need to be flexible to reach a deal.
House Speaker Mike Johnson, a staunch Trump loyalist, had resisted allowing the measure onto the floor, reflecting deep divisions within his party over the program.
But a handful of centrist Republicans joined Democrats in using a rarely successful procedural maneuver -- a discharge petition -- to force the vote over leadership's objections.
Ultimately, 17 Republicans voted with Democrats to pass the bill, a public break that underscored growing anxiety among lawmakers from competitive districts about voter backlash over rising healthcare costs.
"The affordability crisis is not a hoax. It is very real despite what Donald Trump has had to say," Hakeem Jeffries, the leader of the House Democratic minority, told reporters.
"Housing costs are too high. Grocery costs are too high. Utility bills are too high. Childcare costs are too high. And healthcare costs are out of control."
The subsidies were originally created under the Affordable Care Act and expanded during the Covid-19 pandemic, making coverage cheaper and available to more people. An estimated 22 million Americans currently benefit from the enhanced assistance.
The bill now heads to the Senate, where its fate is uncertain. A similar three-year extension failed there in December, falling short of the 60-vote threshold needed to advance.
The nonpartisan Congressional Budget Office estimates a three-year clean extension of enhanced Obamacare subsidies would cost almost $81 billion over a decade -- but would lead to eight million more people getting health insurance by 2029.
The House vote appears to have injected new momentum into bipartisan talks now underway in the upper chamber.
A small group of senators from both parties has been negotiating a narrower compromise that could include a shorter extension, tighter income limits and new options for directing aid straight to patients rather than insurers.
O.Farraj--SF-PST